Dear colleagues and industry partners, We are thrilled to extend a warm invitation to all of you to join us at CPHI Barcelona 2023, one of the most prestigious events in the pharmaceutical and healthcare industry. Our company is proud to be a part of this incredible event, and we're excited to welcome you to our booth, 7D10. Event Details: Date: 24 Oct, 2023–26 Oct, 2023 Location: Fira Barcelona Gran Via Booth: 7D10 At our booth, you'll have the opportunity to connect with our team, explore our latest products and innovations, and engage in meaningful discussions about the future of the pharmaceutical industry. CPHI Barcelona is a hub for networking and knowledge-sharing, and we look forward to exchanging insights with you. Why Visit Booth 7D10? Discover our cutting-edge pharmaceutical solutions. Learn about our commitment to quality and innovation. Meet our team of experts ready to answer your questions. Explore potential collaborations and partnerships. To make the most of your visit, please schedule an appointment with us in advance by contactingsales@sinopeg.com. We believe that collaboration is key to driving the industry forward, and CPHI Barcelona provides the perfect platform for such collaboration.     We can't wait to see you there and discuss how we can work together to achieve excellence in the world of pharmaceuticals. Save the date, visit Booth 7D10, and let's shape the future of healthcare together!

The 2nd LNP Formulation & Process Development Summit is returning to Boston to welcome 350+ LNP experts for sharing, learning and networking to turbocharge next generation of LNP development. Welcome to visit SINOPEG at booth no.27. 2nd LNP Formulation & Process Development Summit | April 2023 (lnp-formulation-process-development-pharma.com) #event #Boston Xiamen Sinopeg Biotech Co., Ltd. is dedicated to drug delivery systems and related medical device business, focusing on the research, development, production and sales of high-end drug delivery carriers/auxiliary materials/APIs, medical materials, including but not limited to polyethylene glycol derivatives, lipid products, blood sugar control drug modifiers, block copolymers, ADC/ProTAC linkers, biodegradable polymers, exosomes, viral-like particles, as well as providing CDMO and solution services. These products are widely used in long-acting protein/peptide drugs, COVID-19 mRNA vaccines, small nucleic acid drugs, blood sugar control drugs, macromolecular micelle drugs, liposome drugs, gene therapy drugs, immunosuppressants, ADC drugs, ProTAC drugs, medical hydrogels, and other fields, placing the company in a leading position in the industry.

Cell & Gene Therapy Bioprocessing & Commercialization is the most focused event for cost effective and efficient cell, gene and immunotherapy approaches. CGT delivers the focused science and business content designed specifically for the cell therapy and regenerative medicine fields, while providing a pivotal gathering place for connecting industry, funding sources, government and academia. Welcome to visit us at SINOPEG's Booth#104at CGT, Boston Convention and Exhibition Center, USA from 27th to 30th September. https://informaconnect.com/cell-therapy-bioprocessing/ #event #CGT #Boston SINOPEG is a dynamic science company with professional R&D, Manufacturing and Sales capability. The company is mainly engaged in drug delivery system (DDS) and new medical materials business. Founded in 2011, SINOPEG has a team of highly qualified and science background employee personnel. We devote ourselves to research, develop and produce high quality Polyethylene glycol, Polyethylene glycol derivatives, Block copolymers, Anti-diabetic drug side chains, lipids for LNPs, GalNAc conjugates, ADC and ProTAC Linker, etc. Please contact us at sales@sinopeg.com 

Welcome to visit us at SINOPEG's Booth #2351 at BIO International Convention 2022, San Diego, USA from 13th to 16th June. SINOPEG is mainly engaged in drug delivery system (DDS) and new medical materials business. SINOPEG has a high-level team with strong technical reserve to research, develop and produce high-quality polyethylene glycol, polyethylene glycol derivatives, block copolymers, anti-diabetic drug side chains, lipid excipients (ingredients for mRNA delivery system), ADC and ProTAC Linker, etc. Please contact us at sales@sinopeg.com #BIO

Welcome to visit us at SINOPEG's Booth #137 at Tides USA 2022, Boston, USA from 9th to 12th May. SINOPEG has a high-level team with strong technical reserve to research, develop and produce high-quality polyethylene glycol, polyethylene glycol derivatives, block copolymers, anti-diabetic drug side chains, lipid excipients (ingredients for mRNA delivery system), ADC and ProTAC Linker, etc. Please coutact us at sales@sinopeg.com

Welcome to visit us at SINOPEG's Booth #137 at Tides USA 2022, Boston, USA from 9th to 12th May.

Welcome to visit us at SINOPEG's Booth #2351 at 2022 BIO International Convention, San Diego, CA, the USA from 13th to 16th June. SINOPEG is a dynamic science company with professional R&D, Manufacturing and Sales capability. The company is mainly engaged in drug delivery system (DDS) and new medical materials business. Founded in 2011, SINOPEG has a high-level team with strong technical reserve to research, develop and produce high-quality polyethylene glycol, polyethylene glycol derivatives, block copolymers, anti-diabetic drug side chains, lipid excipients (ingredients for mRNA delivery system), ADC and ProTAC Linker, etc. SINOPEG has a technical team led by overseas returned doctors and foreign experts, established good cooperation relations with well-known universities and research institutes in China, such as Xiamen University, Fudan University and the Institute of Chemistry of Chinese Academy of Sciences. The company has the first-class technology development strength, provides services including the reaction, purification, separation and end product analysis and others according to customer needs. SINOPEG holds 24 IP, 19 pending IP, and 6 DMFs that meet FDA requirements. The company has ISO13485 certification. The laboratory and production workshop are designed and built in accordance with the cGMP standard of FDA. We follow the requirements of ICH-Q7A to organize production at scale, to provide high quality polyethylene glycol derivatives products and services to customers globally.

As COVID-19 continuing in 2021, it is necessary to take preventive measures, to accelerate the speed of research and development of COVID-19 vaccines and drugs, to advocate the innovation of new vaccines technologies, and to build the strength to win this epidemic. VacCon 2022, focus on technical breakthrough of the novel vaccines in post COVID-19 era. It will invite 60+ government regulatory experts, scientists and leading entrepreneurs who specialize in vaccine/ neutralizing antibody/ small molecule novel coronavirus drugs. The theme is "Focusing on technical breakthrough of the novel vaccines in post COVID-19 era", which will discuss the latest clinical development, before project approval and R&D in COVID-19 vaccine and drugs, and the leading practice of innovation and process development of mRNA/recombinant protein/adenovirus vector vaccine under different technical paths. SINOPEG, as one of the few companies in China to achieve the commercial production of lipid nanoparticles delivery materials, also attracted a lot of friends to communicate with us at the booth.